ID
14614
Beschrijving
Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months; ODM derived from: https://clinicaltrials.gov/show/NCT00200512
Link
https://clinicaltrials.gov/show/NCT00200512
Trefwoorden
Versies (1)
- 24-04-16 24-04-16 -
Geüploaded op
24 april 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Parkinson Disease NCT00200512
Eligibility Parkinson Disease NCT00200512
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Medical therapy for psychoses or dementia
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0418981
- UMLS CUI [1,2]
- C0033975
- UMLS CUI [2,1]
- C0418981
- UMLS CUI [2,2]
- C0497327
Beschrijving
Substance use disorder
Datatype
boolean
Alias
- UMLS CUI [1]
- C0038586
Beschrijving
Comorbidity
Datatype
boolean
Alias
- UMLS CUI [1]
- C0009488
Beschrijving
Allergy to pharmacotherapy
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0013216
Beschrijving
Experimental drug
Datatype
boolean
Alias
- UMLS CUI [1]
- C0304229
Beschrijving
Apomorphine regimen
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0003596
- UMLS CUI [1,2]
- C0040808
Beschrijving
Informed consent
Datatype
boolean
Alias
- UMLS CUI [1]
- C0021430
Similar models
Eligibility Parkinson Disease NCT00200512
- StudyEvent: Eligibility
C0451215 (UMLS CUI [2])
C0360140 (UMLS CUI [2])
C0178601 (UMLS CUI [3])
C0178602 (UMLS CUI [1,2])
C0033975 (UMLS CUI [1,2])
C0418981 (UMLS CUI [2,1])
C0497327 (UMLS CUI [2,2])
C0013216 (UMLS CUI [1,2])
C0040808 (UMLS CUI [1,2])
Geen commentaren